APA (7th ed.) Citation

Yusuf, S., Teo, K., Anderson, C., Pogue, J., Dyal, L., Copland, I., . . . Sleight, P. (2008). Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. The Lancet (British edition), 372(9644), 1174-1183. https://doi.org/10.1016/S0140-6736(08)61242-8

Chicago Style (17th ed.) Citation

Yusuf, S., K. Teo, C. Anderson, J. Pogue, L. Dyal, I. Copland, H. Schumacher, G. Dagenais, and P. Sleight. "Effects of the Angiotensin-receptor Blocker Telmisartan on Cardiovascular Events in High-risk Patients Intolerant to Angiotensin-converting Enzyme Inhibitors: A Randomised Controlled Trial." The Lancet (British Edition) 372, no. 9644 (2008): 1174-1183. https://doi.org/10.1016/S0140-6736(08)61242-8.

MLA (9th ed.) Citation

Yusuf, S., et al. "Effects of the Angiotensin-receptor Blocker Telmisartan on Cardiovascular Events in High-risk Patients Intolerant to Angiotensin-converting Enzyme Inhibitors: A Randomised Controlled Trial." The Lancet (British Edition), vol. 372, no. 9644, 2008, pp. 1174-1183, https://doi.org/10.1016/S0140-6736(08)61242-8.